We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
GNC Gains as Buyout Rumors of Vitamin Shoppe Resurface
Read MoreHide Full Article
Over the past few quarters, the health and wellness retail chain, GNC Holdings Inc. (GNC - Free Report) has recorded a significant sales dip resulting in a continuous downtrend in its shares. However, the rumor to take over its rival and multi-channel specialty retailer Vitamin Shoppe, Inc. that has been doing the rounds for quite some time, has provided a slight impetus.
Accordingly, yesterday, with GNC’s sudden cancellation of an appearance at the Jefferies 2016 Consumer Conference (as informed by Seeking Alpha), the hope of the merger to materialize soon has resurfaced, driving shares of the company up by 2.63% at closing.
The Vitamin Shoppe buyout story first buzzed in immediately after the company’s earnings call in the last quarter. GNC had announced that in response to its continuous sales dip, its board of directors had commenced a wide range of strategic and financial alternatives to increase shareholder value. The review emphasized potential value-maximizing alternatives such as partnerships and other value-creating collaborations, or a potential sale of the company among many other probable strategies. These initiatives came as a major boost for investors, resulting in an immediate 7% rise in share price on May 2.
Although the market has reacted positively so far to the rumor, it is hard for the broker firms to come to a definite conclusion. While JP Morgan is positive about the potential tie-up between GNC and Vitamin Shoppe, Morgan Stanley is still concerned about GNC’s ongoing struggle with its top line due to the lack of product innovation, weak distribution controls and dependence on promotions.
While both GNC and Vitamin Shoppe are in their lackluster phase of growth, analysts are doubtful whether the combination will fetch something fruitful for the consolidated business anytime soon. According to an article by Shelly Banjo in Triblive, “…it's not like either company has an A+ management team capable of figuring out how to turn two struggling retailers into one, big successful company.”
Zacks Rank & Key Picks
Currently, GNC Holdings has a Zacks Rank #4 (Sell). Better-ranked medical stocks are Baxter International Inc. (BAX - Free Report) , Herbalife Ltd. (HLF - Free Report) and Boston Scientific Corp. (BSX - Free Report) . All the three stocks hold a Zacks Rank #2 (Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
GNC Gains as Buyout Rumors of Vitamin Shoppe Resurface
Over the past few quarters, the health and wellness retail chain, GNC Holdings Inc. (GNC - Free Report) has recorded a significant sales dip resulting in a continuous downtrend in its shares. However, the rumor to take over its rival and multi-channel specialty retailer Vitamin Shoppe, Inc. that has been doing the rounds for quite some time, has provided a slight impetus.
Accordingly, yesterday, with GNC’s sudden cancellation of an appearance at the Jefferies 2016 Consumer Conference (as informed by Seeking Alpha), the hope of the merger to materialize soon has resurfaced, driving shares of the company up by 2.63% at closing.
The Vitamin Shoppe buyout story first buzzed in immediately after the company’s earnings call in the last quarter. GNC had announced that in response to its continuous sales dip, its board of directors had commenced a wide range of strategic and financial alternatives to increase shareholder value. The review emphasized potential value-maximizing alternatives such as partnerships and other value-creating collaborations, or a potential sale of the company among many other probable strategies. These initiatives came as a major boost for investors, resulting in an immediate 7% rise in share price on May 2.
Although the market has reacted positively so far to the rumor, it is hard for the broker firms to come to a definite conclusion. While JP Morgan is positive about the potential tie-up between GNC and Vitamin Shoppe, Morgan Stanley is still concerned about GNC’s ongoing struggle with its top line due to the lack of product innovation, weak distribution controls and dependence on promotions.
While both GNC and Vitamin Shoppe are in their lackluster phase of growth, analysts are doubtful whether the combination will fetch something fruitful for the consolidated business anytime soon. According to an article by Shelly Banjo in Triblive, “…it's not like either company has an A+ management team capable of figuring out how to turn two struggling retailers into one, big successful company.”
Zacks Rank & Key Picks
Currently, GNC Holdings has a Zacks Rank #4 (Sell). Better-ranked medical stocks are Baxter International Inc. (BAX - Free Report) , Herbalife Ltd. (HLF - Free Report) and Boston Scientific Corp. (BSX - Free Report) . All the three stocks hold a Zacks Rank #2 (Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>